In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.
The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.
“Oh, crap,” Secrist said to herself.
A new ultra-small and ultra-flexible electronic neural implant, delivered via blood vessels, can record single-neuron activity deep within the brains of rats, according to new
The FDA on Tuesday tentatively approved a pediatric version of an HIV-1 treatment following a successful public-private partnership between the Clinton Health Access Initiative, Unitaid,
Researchers evaluate the effectiveness of artificial intelligence algorithms in non-invasively predicting embryonic ploidy from embryonic images.